Abstract
Objectives To determine if hematology test results can indicate COVID-19 infection.
Methods A cohort study used 2020 Brazilian hospital data for 6,573 patients to run inferential analyses of fourteen red and white blood cell hematology test results, adjusted for age and sex, by patient COVID-19 status.
Results Ten hematological biomarkers were statistically significant predictors of COVID-19 PCR test results; the strongest were Total White Blood Cells: OR=0.90 (0.88-0.93), Basophils: OR=0.97 (0.97-0.98), Total Red Blood Cells: OR=0.88 (0.78-0.99), Hemoglobin: OR=0.93 (0.89-0.97), Hematocrit: OR=0.97 (0.96-0.99). Patient sex was also a strong predictor of COVID-19 PCR test results: OR=1.43 (1.26-1.62).
Conclusions COVID-19 produces measurable impacts on red and white blood cells that are significant predictors of PCR results. A routine blood draw may offer probabilistic insight as a diagnostic predictor of infection. The virus is associated with impacts in red blood cells’ vital oxygen transport attributes.
Public Health Implications A faster diagnostic tool for COVID-19 will assist providers to triage and isolate those with the virus, reducing hospital transmission. Results are being used to develop a predictive model with high sensitivity and specificity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://repositoriodatasharingfapesp.uspdigital.usp.br/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
